{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:27:42Z","timestamp":1791239262973,"version":"4.1.0"},"posted":{"date-parts":[[2023,2,21]]},"group-title":"In Review","reference-count":113,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,12,18]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n Growing evidence has demonstrated that DNA methylation (DNAm) plays an important role in Alzheimer's disease (AD) and that DNAm differences can be detected in the blood of AD subjects. Most studies have correlated blood DNAm with the clinical diagnosis of AD in living individuals. However, as the pathophysiological process of AD can begin many years before the onset of clinical symptoms, there is often disagreement between neuropathology in the brain and clinical phenotypes. Therefore, blood DNAm associated with AD neuropathology, rather than with clinical data, would provide more relevant information on AD pathogenesis.\nMethods\n We performed a comprehensive analysis to identify blood DNAm associated with cerebrospinal fluid (CSF) pathological biomarkers for AD. Our study included matched samples of whole blood DNA methylation, CSF A\u03b2<sub>42<\/sub>, phosphorylated tau<sub>181<\/sub> (pTau<sub>181<\/sub>), and total tau (tTau) biomarkers data, measured on the same subjects and at the same clinical visits from a total of 202 subjects (123 CN or cognitively normal, 79 AD) in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) cohort. To validate our findings, we also examined the association between premortem blood DNAm and postmortem brain neuropathology measured on a group of 69 subjects in the London dataset.\nResults\n We identified a number of novel associations between blood DNAm and CSF biomarkers, demonstrating that changes in pathological processes in the CSF are reflected in the blood epigenome. Overall, the CSF biomarker-associated DNAm is relatively distinct in CN and AD subjects, highlighting the importance of analyzing omics data measured on cognitively normal subjects (which includes preclinical AD subjects) to identify diagnostic biomarkers, and considering disease stages in the development and testing of AD treatment strategies. Moreover, our analysis revealed biological processes associated with early brain impairment relevant to AD are marked by DNAm in the blood, and blood DNAm at several CpGs in the DMR on <italic>HOXA5<\/italic> gene are associated with pTau<sub>181<\/sub> in the CSF, as well as tau-pathology and DNAm in the brain, nominating DNAm at this locus as a promising candidate AD biomarker.\nConclusions\n Our study provides a valuable resource for future mechanistic and biomarker studies of DNAm in AD.<\/p>","DOI":"10.21203\/rs.3.rs-2391364\/v1","type":"posted-content","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T16:24:53Z","timestamp":1676996693000},"source":"Crossref","is-referenced-by-count":2,"title":["Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjects"],"prefix":"10.21203","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"University of Miami, Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Young","sequence":"additional","affiliation":[{"name":"Dr. John T Macdonald Foundation, University of Miami, Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lissette","family":"Gomez","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Dr. John T Macdonald Foundation, University of Miami, Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lukacsovich","sequence":"additional","affiliation":[{"name":"University of Miami, Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achintya","family":"Varma","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Steven","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Miami, Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden R.","family":"Martin","sequence":"additional","affiliation":[{"name":"Dr. John T Macdonald Foundation, University of Miami, Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Wang","sequence":"additional","affiliation":[{"name":"University of Miami, Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8761","reference":[{"key":"ref1","author":"Rajan KB","year":"2021","unstructured":"Rajan, K.B. et al. Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020\u20132060). Alzheimers Dement (2021)."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","article-title":"Monetary costs of dementia in the United States","volume":"368","author":"Hurd MD","year":"2013","unstructured":"Hurd, M.D., Martorell, P., Delavande, A., Mullen, K.J. & Langa, K.M. Monetary costs of dementia in the United States. N Engl J Med 368, 1326\u201334 (2013).","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nn.3792","article-title":"The epigenetic landscape of Alzheimer's disease","volume":"17","author":"Lord J","year":"2014","unstructured":"Lord, J. & Cruchaga, C. The epigenetic landscape of Alzheimer's disease. Nat Neurosci 17, 1138\u201340 (2014).","journal-title":"Nat Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-016-1612-7","article-title":"The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism","volume":"132","author":"Klein HU","year":"2016","unstructured":"Klein, H.U., Bennett, D.A. & De Jager, P.L. The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism. Acta Neuropathol 132, 503\u201314 (2016).","journal-title":"Acta Neuropathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2217\/nmt-2018-0004","article-title":"Role of epigenetics in Alzheimer's disease pathogenesis","volume":"8","author":"Stoccoro A","year":"2018","unstructured":"Stoccoro, A. & Coppede, F. Role of epigenetics in Alzheimer's disease pathogenesis. Neurodegener Dis Manag 8, 181\u2013193 (2018).","journal-title":"Neurodegener Dis Manag"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nn.3786","article-title":"Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci","volume":"17","author":"Jager PL","year":"2014","unstructured":"De Jager, P.L. et al. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci 17, 1156\u201363 (2014).","journal-title":"Nat Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nn.3782","article-title":"Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease","volume":"17","author":"Lunnon K","year":"2014","unstructured":"Lunnon, K. et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease. Nat Neurosci 17, 1164\u201370 (2014).","journal-title":"Nat Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jalz.2018.01.017","article-title":"Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology","volume":"14","author":"Smith RG","year":"2018","unstructured":"Smith, R.G. et al. Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology. Alzheimers Dement 14, 1580\u20131588 (2018).","journal-title":"Alzheimers Dement"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1038\/s41467-020-19791-w","article-title":"Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer's disease","volume":"11","author":"Zhang L","year":"2020","unstructured":"Zhang, L. et al. Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer's disease. Nat Commun 11, 6114 (2020).","journal-title":"Nat Commun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40478-021-01177-8","article-title":"Sex-specific DNA methylation differences in Alzheimer's disease pathology","volume":"9","author":"Zhang L","year":"2021","unstructured":"Zhang, L. et al. Sex-specific DNA methylation differences in Alzheimer's disease pathology. Acta Neuropathol Commun 9, 77 (2021).","journal-title":"Acta Neuropathol Commun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.2217\/epi-2020-0236","article-title":"DNA methylation analysis of candidate genes associated with dementia in peripheral blood","volume":"12","author":"Fransquet PD","year":"2020","unstructured":"Fransquet, P.D. et al. DNA methylation analysis of candidate genes associated with dementia in peripheral blood. Epigenomics 12, 2109\u20132123 (2020).","journal-title":"Epigenomics"},{"key":"ref12","first-page":"e12056","article-title":"Blood DNA methylation signatures to detect dementia prior to overt clinical symptoms","volume":"12","author":"Fransquet PD","year":"2020","unstructured":"Fransquet, P.D. et al. Blood DNA methylation signatures to detect dementia prior to overt clinical symptoms. Alzheimers Dement (Amst) 12, e12056 (2020).","journal-title":"Alzheimers Dement (Amst)"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"12217","DOI":"10.1038\/s41598-020-69248-9","article-title":"Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease","volume":"10","author":"Kobayashi N","year":"2020","unstructured":"Kobayashi, N. et al. Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease. Sci Rep 10, 12217 (2020).","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neurobiolaging.2020.06.023","article-title":"An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene","volume":"95","author":"Roubroeks JAY","year":"2020","unstructured":"Roubroeks, J.A.Y. et al. An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene. Neurobiol Aging 95, 26\u201345 (2020).","journal-title":"Neurobiol Aging"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3233\/JAD-180592","article-title":"DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease","volume":"66","author":"Madrid A","year":"2018","unstructured":"Madrid, A. et al. DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease. J Alzheimers Dis 66, 927\u2013934 (2018).","journal-title":"J Alzheimers Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e0239196","DOI":"10.1371\/journal.pone.0239196","article-title":"Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients","volume":"15","author":"Mitsumori R","year":"2020","unstructured":"Mitsumori, R. et al. Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients. PLoS One 15, e0239196 (2020).","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1038\/s41467-022-32475-x","article-title":"Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer's disease","volume":"13","year":"2022","unstructured":"T, C.S. et al. Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer's disease. Nat Commun 13, 4852 (2022).","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack CR","year":"2010","unstructured":"Jack, C.R., Jr. et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119\u201328 (2010).","journal-title":"Lancet Neurol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling RA","year":"2011","unstructured":"Sperling, R.A. et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280\u201392 (2011).","journal-title":"Alzheimers Dement"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2021.5216","article-title":"Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum","author":"Jansen WJ","year":"2022","unstructured":"Jansen, W.J. et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol (2022).","journal-title":"JAMA Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis","volume":"313","author":"Ossenkoppele R","year":"2015","unstructured":"Ossenkoppele, R. et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA 313, 1939\u201349 (2015).","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e0182098","DOI":"10.1371\/journal.pone.0182098","article-title":"Alzheimer's Disease Neuroimaging, I. A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression","volume":"12","author":"Llano DA","year":"2017","unstructured":"Llano, D.A., Bundela, S., Mudar, R.A., Devanarayan, V. & Alzheimer's Disease Neuroimaging, I. A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression. PLoS One 12, e0182098 (2017).","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"19024","DOI":"10.1038\/s41598-019-54204-z","article-title":"Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Abeta(1\u201342), pTau and tTau CSF immunoassays","volume":"9","author":"Blennow K","year":"2019","unstructured":"Blennow, K. et al. Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Abeta(1\u201342), pTau and tTau CSF immunoassays. Sci Rep 9, 19024 (2019).","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","article-title":"Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?","volume":"60","author":"Clark CM","year":"2003","unstructured":"Clark, C.M. et al. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60, 1696\u2013702 (2003).","journal-title":"Arch Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw LM","year":"2009","unstructured":"Shaw, L.M. et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65, 403\u201313 (2009).","journal-title":"Ann Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk D","year":"2003","unstructured":"Strozyk, D., Blennow, K., White, L.R. & Launer, L.J. CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60, 652\u20136 (2003).","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola T","year":"2009","unstructured":"Tapiola, T. et al. Cerebrospinal fluid beta-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66, 382\u20139 (2009).","journal-title":"Arch Neurol"},{"key":"ref28","article-title":"Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy","author":"Grothe MJ","year":"2021","unstructured":"Grothe, M.J. et al. Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy. Neurology (2021).","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack CR","year":"2018","unstructured":"Jack, C.R., Jr. et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement"},{"key":"ref30","author":"Jack CR","year":"2016","unstructured":"Jack, C.R., Jr. et al. A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539 \u2013 47 (2016)."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jalz.2018.08.005","article-title":"Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative","volume":"15","author":"Veitch DP","year":"2019","unstructured":"Veitch, D.P. et al. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement 15, 106\u2013152 (2019).","journal-title":"Alzheimers Dement"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/epi.23470","article-title":"Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray","volume":"8","author":"Chen YA","year":"2013","unstructured":"Chen, Y.A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8, 203\u20139 (2013).","journal-title":"Epigenetics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/15592294.2015.1057384","article-title":"A systematic study of normalization methods for Infinium 450K methylation data using whole-genome bisulfite sequencing data","volume":"10","author":"Wang T","year":"2015","unstructured":"Wang, T. et al. A systematic study of normalization methods for Infinium 450K methylation data using whole-genome bisulfite sequencing data. Epigenetics 10, 662\u20139 (2015).","journal-title":"Epigenetics"},{"key":"ref34","author":"Teschendorff AE","year":"2013","unstructured":"Teschendorff, A.E. et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29, 189 \u2013 96 (2013)."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12859-017-1511-5","article-title":"A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies","volume":"18","author":"Teschendorff AE","year":"2017","unstructured":"Teschendorff, A.E., Breeze, C.E., Zheng, S.C. & Beck, S. A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies. BMC Bioinformatics 18, 105 (2017).","journal-title":"BMC Bioinformatics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13059-021-02275-5","article-title":"Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders","volume":"22","author":"Nabais MF","year":"2021","unstructured":"Nabais, M.F. et al. Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. Genome Biol 22, 90 (2021).","journal-title":"Genome Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13148-020-00864-y","article-title":"Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease","volume":"12","author":"Vasanthakumar A","year":"2020","unstructured":"Vasanthakumar, A. et al. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease. Clin Epigenetics 12, 84 (2020).","journal-title":"Clin Epigenetics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","article-title":"Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers","volume":"133","author":"Deming Y","year":"2017","unstructured":"Deming, Y. et al. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers. Acta Neuropathol 133, 839\u2013856 (2017).","journal-title":"Acta Neuropathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00401-018-1881-4","article-title":"Sex-specific genetic predictors of Alzheimer's disease biomarkers","volume":"136","author":"Deming Y","year":"2018","unstructured":"Deming, Y. et al. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136, 857\u2013872 (2018).","journal-title":"Acta Neuropathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.0006-341X.1999.00997.x","article-title":"Genomic Control for Association Studies","volume":"55","author":"Delvin B","year":"1999","unstructured":"Delvin, B. & Roeder, K. Genomic Control for Association Studies. Biometrics 55, 997\u20131004 (1999).","journal-title":"Biometrics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13059-016-1131-9","article-title":"Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution","volume":"18","author":"Iterson M","year":"2017","unstructured":"van Iterson, M., van Zwet, E.W., Consortium, B. & Heijmans, B.T. Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution. Genome Biol 18, 19 (2017).","journal-title":"Genome Biol"},{"key":"ref42","author":"Silva TC","year":"2022","unstructured":"Silva, T.C. et al. Cross-tissue meta-analysis of blood and brain epigenome-wide association studies in Alzheimer\u2019s disease. Nature Communications, In Press (2022)."},{"key":"ref43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fnagi.2017.00413","article-title":"Epigenome-Wide Association Study of Cognitive Functioning in Middle-Aged Monozygotic Twins","volume":"9","author":"Starnawska A","year":"2017","unstructured":"Starnawska, A. et al. Epigenome-Wide Association Study of Cognitive Functioning in Middle-Aged Monozygotic Twins. Front Aging Neurosci 9, 413 (2017).","journal-title":"Front Aging Neurosci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1093\/bioinformatics\/bts545","article-title":"Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values","volume":"28","author":"Pedersen BS","year":"2012","unstructured":"Pedersen, B.S., Schwartz, D.A., Yang, I.V. & Kechris, K.J. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics 28, 2986\u20138 (2012).","journal-title":"Bioinformatics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/bib\/bby085","article-title":"An evaluation of supervised methods for identifying differentially methylated regions in Illumina methylation arrays","volume":"20","author":"Mallik S","year":"2019","unstructured":"Mallik, S. et al. An evaluation of supervised methods for identifying differentially methylated regions in Illumina methylation arrays. Brief Bioinform 20, 2224\u20132235 (2019).","journal-title":"Brief Bioinform"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.1630","article-title":"GREAT improves functional interpretation of cis-regulatory regions","volume":"28","author":"McLean CY","year":"2010","unstructured":"McLean, C.Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 28, 495\u2013501 (2010).","journal-title":"Nat Biotechnol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41586-021-03446-x","article-title":"Genome-wide enhancer maps link risk variants to disease genes","volume":"593","author":"Nasser J","year":"2021","unstructured":"Nasser, J. et al. Genome-wide enhancer maps link risk variants to disease genes. Nature 593, 238\u2013243 (2021).","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/bioinformatics\/bty892","article-title":"methylGSA: a Bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing","volume":"35","author":"Ren X","year":"2019","unstructured":"Ren, X. & Kuan, P.F. methylGSA: a Bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing. Bioinformatics 35, 1958\u20131959 (2019).","journal-title":"Bioinformatics"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian A","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545\u201350 (2005).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"D109-14","DOI":"10.1093\/nar\/gkr988","article-title":"KEGG for integration and interpretation of large-scale molecular data sets","volume":"40","author":"Kanehisa M","year":"2012","unstructured":"Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40, D109-14 (2012).","journal-title":"Nucleic Acids Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"D687-D692","DOI":"10.1093\/nar\/gkab1028","article-title":"The reactome pathway knowledgebase 2022","volume":"50","author":"Gillespie M","year":"2022","unstructured":"Gillespie, M. et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res 50, D687-D692 (2022).","journal-title":"Nucleic Acids Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran D","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A.J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 18, 220 (2017).","journal-title":"Genome Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41588-021-00923-x","article-title":"Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation","volume":"53","author":"Min JL","year":"2021","unstructured":"Min, J.L. et al. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation. Nat Genet 53, 1311\u20131321 (2021).","journal-title":"Nat Genet"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle BW","year":"2019","unstructured":"Kunkle, B.W. et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51, 414\u2013430 (2019).","journal-title":"Nat Genet"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13059-018-1448-7","article-title":"An optimized library for reference-based deconvolution of whole-blood biospecimens assayed using the Illumina HumanMethylationEPIC BeadArray","volume":"19","author":"Salas LA","year":"2018","unstructured":"Salas, L.A. et al. An optimized library for reference-based deconvolution of whole-blood biospecimens assayed using the Illumina HumanMethylationEPIC BeadArray. Genome Biol 19, 64 (2018).","journal-title":"Genome Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1080\/15592294.2015.1100786","article-title":"Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes","volume":"10","author":"Hannon E","year":"2015","unstructured":"Hannon, E., Lunnon, K., Schalkwyk, L. & Mill, J. Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes. Epigenetics 10, 1024\u201332 (2015).","journal-title":"Epigenetics"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer's disease-related neurofibrillary changes","volume":"16","author":"Braak H","year":"1995","unstructured":"Braak, H. & Braak, E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 16, 271\u20138; discussion 278 \u2013 84 (1995).","journal-title":"Neurobiol Aging"},{"key":"ref58","author":"Mukherjee S","year":"1988","unstructured":"Mukherjee, S., Erickson, H. & Bastia, D. Enhancer-origin interaction in plasmid R6K involves a DNA loop mediated by initiator protein. Cell 52, 375 \u2013 83 (1988)."},{"key":"ref59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuint.2015.01.008","article-title":"Lo Bello, M. Glutathione transferases and neurodegenerative diseases","volume":"82","author":"Mazzetti AP","year":"2015","unstructured":"Mazzetti, A.P., Fiorile, M.C., Primavera, A. & Lo Bello, M. Glutathione transferases and neurodegenerative diseases. Neurochem Int 82, 10\u20138 (2015).","journal-title":"Neurochem Int"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/13543776.2017.1254192","article-title":"Role of Glutathione-S-transferases in neurological problems","volume":"27","author":"Kumar A","year":"2017","unstructured":"Kumar, A. et al. Role of Glutathione-S-transferases in neurological problems. Expert Opin Ther Pat 27, 299\u2013309 (2017).","journal-title":"Expert Opin Ther Pat"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1038\/s41598-021-83872-z","article-title":"Defining early changes in Alzheimer's disease from RNA sequencing of brain regions differentially affected by pathology","volume":"11","author":"Guennewig B","year":"2021","unstructured":"Guennewig, B. et al. Defining early changes in Alzheimer's disease from RNA sequencing of brain regions differentially affected by pathology. Sci Rep 11, 4865 (2021).","journal-title":"Sci Rep"},{"key":"ref62","author":"Nandi A","year":"2019","unstructured":"Nandi, A., Yan, L.J., Jana, C.K. & Das, N. Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases. Oxid Med Cell Longev 2019, 9613090 (2019)."},{"key":"ref63","doi-asserted-by":"crossref","first-page":"38933","DOI":"10.1074\/jbc.M110.132860","article-title":"Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity","volume":"285","author":"Habib LK","year":"2010","unstructured":"Habib, L.K., Lee, M.T. & Yang, J. Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity. J Biol Chem 285, 38933\u201343 (2010).","journal-title":"J Biol Chem"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/138920212802510448","article-title":"Characterization of the early CNS stress biomarkers and profiles associated with neuropsychiatric diseases","volume":"13","author":"Lowe X","year":"2012","unstructured":"Lowe, X. & Wyrobek, A. Characterization of the early CNS stress biomarkers and profiles associated with neuropsychiatric diseases. Curr Genomics 13, 489\u201397 (2012).","journal-title":"Curr Genomics"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1176935119828776","DOI":"10.1177\/1176935119828776","article-title":"Correlation Patterns Between DNA Methylation and Gene Expression in The Cancer Genome Atlas","volume":"18","author":"Spainhour JC","year":"2019","unstructured":"Spainhour, J.C., Lim, H.S., Yi, S.V. & Qiu, P. Correlation Patterns Between DNA Methylation and Gene Expression in The Cancer Genome Atlas. Cancer Inform 18, 1176935119828776 (2019).","journal-title":"Cancer Inform"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"23882","DOI":"10.1074\/jbc.M114.573469","article-title":"Paradoxical role of DNA methylation in activation of FoxA2 gene expression during endoderm development","volume":"289","author":"Bahar Halpern K","year":"2014","unstructured":"Bahar Halpern, K., Vana, T. & Walker, M.D. Paradoxical role of DNA methylation in activation of FoxA2 gene expression during endoderm development. J Biol Chem 289, 23882\u201392 (2014).","journal-title":"J Biol Chem"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2199-8-20","article-title":"Sp1\/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells","volume":"8","author":"Hantusch B","year":"2007","unstructured":"Hantusch, B., Kalt, R., Krieger, S., Puri, C. & Kerjaschki, D. Sp1\/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. BMC Mol Biol 8, 20 (2007).","journal-title":"BMC Mol Biol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"38914","DOI":"10.1074\/jbc.M504633200","article-title":"Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX","volume":"280","author":"Niesen MI","year":"2005","unstructured":"Niesen, M.I. et al. Activation of a methylated promoter mediated by a sequence-specific DNA-binding protein, RFX. J Biol Chem 280, 38914\u201322 (2005).","journal-title":"J Biol Chem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrg.2016.83","article-title":"Transcription factors as readers and effectors of DNA methylation","volume":"17","author":"Zhu H","year":"2016","unstructured":"Zhu, H., Wang, G. & Qian, J. Transcription factors as readers and effectors of DNA methylation. Nat Rev Genet 17, 551\u201365 (2016).","journal-title":"Nat Rev Genet"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1042\/EBC20190033","article-title":"Sensitivity of transcription factors to DNA methylation","volume":"63","author":"Heberle E","year":"2019","unstructured":"Heberle, E. & Bardet, A.F. Sensitivity of transcription factors to DNA methylation. Essays Biochem 63, 727\u2013741 (2019).","journal-title":"Essays Biochem"},{"key":"ref71","article-title":"Impact of cytosine methylation on DNA binding specificities of human transcription factors","volume":"356","author":"Yin Y","year":"2017","unstructured":"Yin, Y. et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science 356(2017).","journal-title":"Science"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"e00726","DOI":"10.7554\/eLife.00726","article-title":"DNA methylation presents distinct binding sites for human transcription factors","volume":"2","author":"Hu S","year":"2013","unstructured":"Hu, S. et al. DNA methylation presents distinct binding sites for human transcription factors. Elife 2, e00726 (2013).","journal-title":"Elife"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"e51-e51","DOI":"10.1093\/nar\/gkac030","article-title":"MethReg: estimating the regulatory potential of DNA methylation in gene transcription","volume":"50","author":"Silva TC","year":"2022","unstructured":"Silva, T.C., Young, J.I., Martin, E.R., Chen, X.S. & Wang, L. MethReg: estimating the regulatory potential of DNA methylation in gene transcription. Nucleic Acids Research 50, e51-e51 (2022).","journal-title":"Nucleic Acids Research"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng.3721","article-title":"Disease variants alter transcription factor levels and methylation of their binding sites","volume":"49","author":"Bonder MJ","year":"2017","unstructured":"Bonder, M.J. et al. Disease variants alter transcription factor levels and methylation of their binding sites. Nat Genet 49, 131\u2013138 (2017).","journal-title":"Nat Genet"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"e1004663","DOI":"10.1371\/journal.pgen.1004663","article-title":"Methylation QTLs are associated with coordinated changes in transcription factor binding, histone modifications, and gene expression levels","volume":"10","author":"Banovich NE","year":"2014","unstructured":"Banovich, N.E. et al. Methylation QTLs are associated with coordinated changes in transcription factor binding, histone modifications, and gene expression levels. PLoS Genet 10, e1004663 (2014).","journal-title":"PLoS Genet"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/acn3.201","article-title":"Alzheimer's loci: epigenetic associations and interaction with genetic factors","volume":"2","author":"Chibnik LB","year":"2015","unstructured":"Chibnik, L.B. et al. Alzheimer's loci: epigenetic associations and interaction with genetic factors. Ann Clin Transl Neurol 2, 636\u201347 (2015).","journal-title":"Ann Clin Transl Neurol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"111cm33","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target and right drug at the right stage","volume":"3","author":"Sperling RA","year":"2011","unstructured":"Sperling, R.A., Jack, C.R., Jr. & Aisen, P.S. Testing the right target and right drug at the right stage. Sci Transl Med 3, 111cm33 (2011).","journal-title":"Sci Transl Med"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"17708","DOI":"10.1038\/s41598-022-21820-1","article-title":"Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials","volume":"12","author":"Mortberg MA","year":"2022","unstructured":"Mortberg, M.A., Vallabh, S.M. & Minikel, E.V. Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials. Sci Rep 12, 17708 (2022).","journal-title":"Sci Rep"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gene.2009.11.006","article-title":"Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations","volume":"451","author":"Wang Y","year":"2010","unstructured":"Wang, Y., Gao, L., Tse, S.W. & Andreadis, A. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations. Gene 451, 23\u201331 (2010).","journal-title":"Gene"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"e1728","DOI":"10.1002\/wrna.1728","article-title":"RNA splicing regulators play critical roles in neurogenesis","author":"Fisher E","year":"2022","unstructured":"Fisher, E. & Feng, J. RNA splicing regulators play critical roles in neurogenesis. Wiley Interdiscip Rev RNA, e1728 (2022).","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2458-10-298","article-title":"Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH)","volume":"10","author":"Bensenor IM","year":"2010","unstructured":"Bensenor, I.M., Lotufo, P.A., Menezes, P.R. & Scazufca, M. Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH). BMC Public Health 10, 298 (2010).","journal-title":"BMC Public Health"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-2265.2000.01146.x","article-title":"Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study","volume":"53","author":"Kalmijn S","year":"2000","unstructured":"Kalmijn, S. et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 53, 733\u20137 (2000).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/01.WNL.0000128134.84230.9F","article-title":"Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease","volume":"62","author":"Osch LA","year":"2004","unstructured":"van Osch, L.A., Hogervorst, E., Combrinck, M. & Smith, A.D. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology 62, 1967\u201371 (2004).","journal-title":"Neurology"},{"key":"ref84","first-page":"11","article-title":"A High-Throughput Search for SFXN1 Physical Partners Led to the Identification of ATAD3, HSD10 and TIM50","author":"Tifoun N","year":"2022","unstructured":"Tifoun, N. et al. A High-Throughput Search for SFXN1 Physical Partners Led to the Identification of ATAD3, HSD10 and TIM50. Biology (Basel) 11(2022).","journal-title":"Biology (Basel)"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/acschemneuro.8b00194","article-title":"Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease","volume":"9","author":"Du L","year":"2018","unstructured":"Du, L. et al. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease. ACS Chem Neurosci 9, 1849\u20131857 (2018).","journal-title":"ACS Chem Neurosci"},{"key":"ref86","first-page":"81","article-title":"Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker","volume":"9","author":"Sun Y","year":"2017","unstructured":"Sun, Y. et al. Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker. Front Aging Neurosci 9, 81 (2017).","journal-title":"Front Aging Neurosci"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jmri.28043","article-title":"Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension","volume":"56","author":"Qin Z","year":"2022","unstructured":"Qin, Z. et al. Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension. J Magn Reson Imaging 56, 508\u2013515 (2022).","journal-title":"J Magn Reson Imaging"},{"key":"ref88","first-page":"11","article-title":"The Role of BMI1 in Late-Onset Sporadic Alzheimer's Disease","author":"Hogan R","year":"2020","unstructured":"Hogan, R., Flamier, A., Nardini, E. & Bernier, G. The Role of BMI1 in Late-Onset Sporadic Alzheimer's Disease. Genes (Basel) 11(2020).","journal-title":"Genes (Basel)"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.celrep.2018.04.097","article-title":"Modeling Late-Onset Sporadic Alzheimer's Disease through BMI1 Deficiency","volume":"23","author":"Flamier A","year":"2018","unstructured":"Flamier, A. et al. Modeling Late-Onset Sporadic Alzheimer's Disease through BMI1 Deficiency. Cell Rep 23, 2653\u20132666 (2018).","journal-title":"Cell Rep"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12974-019-1545-x","article-title":"Differential transcriptional profiles identify microglial- and macrophage-specific gene markers expressed during virus-induced neuroinflammation","volume":"16","author":"DePaula-Silva AB","year":"2019","unstructured":"DePaula-Silva, A.B. et al. Differential transcriptional profiles identify microglial- and macrophage-specific gene markers expressed during virus-induced neuroinflammation. J Neuroinflammation 16, 152 (2019).","journal-title":"J Neuroinflammation"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"R806-9","DOI":"10.1016\/j.cub.2016.07.060","article-title":"Glucose Metabolism: A Sweet Relief of Alzheimer's Disease","volume":"26","author":"Duran-Aniotz C","year":"2016","unstructured":"Duran-Aniotz, C. & Hetz, C. Glucose Metabolism: A Sweet Relief of Alzheimer's Disease. Curr Biol 26, R806-9 (2016).","journal-title":"Curr Biol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-022-00996-8","article-title":"Glucose metabolism and AD: evidence for a potential diabetes type 3","volume":"14","author":"Gonzalez A","year":"2022","unstructured":"Gonzalez, A., Calfio, C., Churruca, M. & Maccioni, R.B. Glucose metabolism and AD: evidence for a potential diabetes type 3. Alzheimers Res Ther 14, 56 (2022).","journal-title":"Alzheimers Res Ther"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/eurheartj\/ehu198","article-title":"The heart of the matter: a link between troponin and dementia?","volume":"35","author":"Nolte CH","year":"2014","unstructured":"Nolte, C.H. & Endres, M. The heart of the matter: a link between troponin and dementia? Eur Heart J 35, 1779\u201381 (2014).","journal-title":"Eur Heart J"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.2012.06482.x","article-title":"The links between complex coronary disease, cerebrovascular disease, and degenerative brain disease","volume":"1254","author":"Kovacic JC","year":"2012","unstructured":"Kovacic, J.C., Castellano, J.M. & Fuster, V. The links between complex coronary disease, cerebrovascular disease, and degenerative brain disease. Ann N Y Acad Sci 1254, 99\u2013105 (2012).","journal-title":"Ann N Y Acad Sci"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2741\/e411","article-title":"Linking atherosclerosis to Alzheimer's disease: focus on biomarkers","volume":"4","author":"Emanuele E","year":"2012","unstructured":"Emanuele, E., Martinelli, V., Abbiati, V. & Ricevuti, G. Linking atherosclerosis to Alzheimer's disease: focus on biomarkers. Front Biosci (Elite Ed) 4, 700\u201310 (2012).","journal-title":"Front Biosci (Elite Ed)"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1747-4949.2011.00731.x","article-title":"Dementia, stroke, and vascular risk factors; a review","volume":"7","author":"Sahathevan R","year":"2012","unstructured":"Sahathevan, R., Brodtmann, A. & Donnan, G.A. Dementia, stroke, and vascular risk factors; a review. Int J Stroke 7, 61\u201373 (2012).","journal-title":"Int J Stroke"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/eurheartj\/ehu124","article-title":"High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study","volume":"35","author":"Schneider AL","year":"2014","unstructured":"Schneider, A.L. et al. High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study. Eur Heart J 35, 1817\u201324 (2014).","journal-title":"Eur Heart J"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bbamcr.2018.07.018","article-title":"Calcium signaling in Alzheimer's disease & therapies","volume":"1865","author":"Tong BC","year":"2018","unstructured":"Tong, B.C., Wu, A.J., Li, M. & Cheung, K.H. Calcium signaling in Alzheimer's disease & therapies. Biochim Biophys Acta Mol Cell Res 1865, 1745\u20131760 (2018).","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref99","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010140","article-title":"Calcium Signalling in Alzheimer's Disease: From Pathophysiological Regulation to Therapeutic Approaches","volume":"10","author":"Chami M","year":"2021","unstructured":"Chami, M. Calcium Signalling in Alzheimer's Disease: From Pathophysiological Regulation to Therapeutic Approaches. Cells 10(2021).","journal-title":"Cells"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2007.03.005","article-title":"Aging is associated with elevated intracellular calcium levels and altered calcium homeostatic mechanisms in hippocampal neurons","volume":"418","author":"Raza M","year":"2007","unstructured":"Raza, M. et al. Aging is associated with elevated intracellular calcium levels and altered calcium homeostatic mechanisms in hippocampal neurons. Neurosci Lett 418, 77\u201381 (2007).","journal-title":"Neurosci Lett"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1523\/JNEUROSCI.5457-12.2013","article-title":"Altered calcium metabolism in aging CA1 hippocampal pyramidal neurons","volume":"33","author":"Oh MM","year":"2013","unstructured":"Oh, M.M., Oliveira, F.A., Waters, J. & Disterhoft, J.F. Altered calcium metabolism in aging CA1 hippocampal pyramidal neurons. J Neurosci 33, 7905\u201311 (2013).","journal-title":"J Neurosci"},{"key":"ref102","author":"Selkoe DJ","year":"2002","unstructured":"Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 298, 789 \u2013 91 (2002)."},{"key":"ref103","author":"Davies CA","year":"1987","unstructured":"Davies, C.A., Mann, D.M., Sumpter, P.Q. & Yates, P.O. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78, 151 \u2013 64 (1987)."},{"key":"ref104","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.brainresrev.2011.01.003","article-title":"Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease","volume":"67","author":"Penzes P","year":"2011","unstructured":"Penzes, P. & Vanleeuwen, J.E. Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease. Brain Res Rev 67, 184\u201392 (2011).","journal-title":"Brain Res Rev"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1523\/JNEUROSCI.3040-05.2005","article-title":"Ribosome dysfunction is an early event in Alzheimer's disease","volume":"25","author":"Ding Q","year":"2005","unstructured":"Ding, Q., Markesbery, W.R., Chen, Q., Li, F. & Keller, J.N. Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci 25, 9171\u20135 (2005).","journal-title":"J Neurosci"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/bpa.12335","article-title":"Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome","volume":"26","author":"Hernandez-Ortega K","year":"2016","unstructured":"Hernandez-Ortega, K., Garcia-Esparcia, P., Gil, L., Lucas, J.J. & Ferrer, I. Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome. Brain Pathol 26, 593\u2013605 (2016).","journal-title":"Brain Pathol"},{"key":"ref107","first-page":"135","article-title":"TRIM proteins and diseases","volume":"161","author":"Watanabe M","year":"2017","unstructured":"Watanabe, M. & Hatakeyama, S. TRIM proteins and diseases. J Biochem 161, 135\u2013144 (2017).","journal-title":"J Biochem"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"220098","DOI":"10.1098\/rsob.220098","article-title":"TRIM family proteins: roles in proteostasis and neurodegenerative diseases","volume":"12","author":"Zhu Y","year":"2022","unstructured":"Zhu, Y., Afolabi, L.O., Wan, X., Shim, J.S. & Chen, L. TRIM family proteins: roles in proteostasis and neurodegenerative diseases. Open Biol 12, 220098 (2022).","journal-title":"Open Biol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jalz.2016.02.009","article-title":"Methylation profiles in peripheral blood CD4 + lymphocytes versus brain: The relation to Alzheimer's disease pathology","volume":"12","author":"Yu L","year":"2016","unstructured":"Yu, L. et al. Methylation profiles in peripheral blood CD4 + lymphocytes versus brain: The relation to Alzheimer's disease pathology. Alzheimers Dement 12, 942\u2013951 (2016).","journal-title":"Alzheimers Dement"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1038\/s41467-022-33394-7","article-title":"DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types","volume":"13","author":"Shireby G","year":"2022","unstructured":"Shireby, G. et al. DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types. Nat Commun 13, 5620 (2022).","journal-title":"Nat Commun"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13195-022-01070-z","article-title":"Distinct sex-specific DNA methylation differences in Alzheimer's disease","volume":"14","author":"T CS","year":"2022","unstructured":"T, C.S. et al. Distinct sex-specific DNA methylation differences in Alzheimer's disease. Alzheimers Res Ther 14, 133 (2022).","journal-title":"Alzheimers Res Ther"},{"key":"ref112","author":"Silva TC","year":"2022","unstructured":"Silva, T.C. et al. Distinct sex-specific DNA methylation differences in Alzheimer\u2019s disease. Alzheimer's Research & Therapy, Invited revision (2022)."},{"key":"ref113","author":"Nettiksimmons J","year":"2014","unstructured":"Nettiksimmons, J., DeCarli, C., Landau, S., Beckett, L. & Alzheimer's Disease Neuroimaging, I. Biological heterogeneity in ADNI amnestic mild cognitive impairment. Alzheimers Dement 10, 511\u2013521 e1 (2014)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2391364\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2391364\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T23:46:03Z","timestamp":1697499963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2391364\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":113,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2391364\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s13195-023-01216-7","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,2,21]]},"subtype":"preprint"}}